David Main
About David Main
David Main: President & CEO of Aquinox Pharmaceuticals
David Main is the President and Chief Executive Officer of Aquinox Pharmaceuticals. He co-founded Aquinox Pharmaceuticals in 2006 and has been pivotal in establishing the company's strategic direction and growth. His leadership brought the company from its private foundation to a successful NASDAQ listing. Additionally, he led the company through its significant merger with Neoleukin Therapeutics, navigating complex transitions and integrations.
David Main's Role in Life Sciences Leadership
David Main has held numerous leadership roles in the life sciences sector. He has chaired several key organizations, including LifeSciences BC, BIOTECanada, and Accel-Rx. His influence extends to serving on the board of directors for BIO.org. These roles highlight his significant contributions to the broader life sciences community, guiding industry standards and fostering innovation.
David Main's Career in the Pharmaceutical Industry
David Main's career in the pharmaceutical industry includes notable positions such as President and CEO of INEX Pharmaceuticals and Vice President at QLT. His experience in these roles has provided him with a deep understanding of pharmaceutical development, business management, and corporate strategy, which he has applied throughout his career to drive company successes and industry advancements.
David Main's Educational Background
David Main holds a Bachelor of Science in Pharmacy and a Master of Business Administration from the University of British Columbia. This combination of technical expertise in pharmacy and strategic business acumen has been fundamental to his ability to lead complex pharmaceutical organizations and navigate the healthcare market effectively.
David Main's Early Career as a Pharmacist
David Main began his professional journey as a licensed pharmacist at the Royal Columbian Hospital in New Westminster, B.C. This early experience in the practical aspects of pharmacy provided him with a robust foundation in patient care and the healthcare system, which has informed his later work in pharmaceutical company management and leadership.